They should do stock buyback.
recoverystaffing
Posts
-
-
It’s a fucking death rattle
-
It needs a restructuring now to stop the cash hemorrhage
-
It’s a Penny stock with a .50 downside here
-
The bloodbath continues without end, there must be something we are not being told
-
Options traders dream here
-
The problem is that the management is so stupid they probably don’t know what to do. Great science horrible management
-
.80 is bottom but it’s setting up for reverse here if they are smart and choke the shorts
-
The only hope is selling the company NOW or we bleed to death slowly and die in a year.
-
About to blastoff, it’s up .01 in the pre
-
Could hit .50
-
I’m afraid of the Q4 numbers actually
-
I hopevAlina Habba is not lead counsel
-
This is all about the court mess
-
The market doesn’t care about science or even the business they only care about share price and this one’s going down
-
The support is at .80 and the selloff will test it. Thank God it’s not tax loss season because every stock has a point of absurdity
-
At least it was a hell of a run to the lucky ones
-
The days of biotech speculation like the past 30+ years appears to be over and stock gains now will be driven by earnings. The lofty multiples finally reflect reality. The only speculation left is in acquisitions and large pharma will wait till the end of a stock collapse to see if they can buy drugs out of BK
-
Until people wake up
-
Stock price has nothing to do with the health of a company and 100% buyers and sellers mood. Amgen could go to 0 and still be Amgen
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE